Table 1.
Demographic and clinical features of admitted COVID-19 patients in Shiraz Transplant Center (N = 77)
| Variable | COVID-19 PCR Positive (%) n = 21 | COVID-19 PCR negative patients but highly suspicious (%) n = 56 |
|---|---|---|
| Age group | ||
| < 40 | 3 (14.3) | 7 (10.7) |
| 40–60 | 10 (47.6) | 17 (28.6) |
| > 60 | 8 (38.1) | 32 (57.1) |
| Gender | ||
| Male | 12 (57.1) | 38 (67.9) |
| Female | 9 (42.9) | 18 (32.1) |
| Residence (Fars province) | ||
| Shiraz (capital of Fars) | 9 (42.9) | 34 (60.7) |
| Other Cities | 12 (57.1) | 22 (39.2) |
| Comorbid diseases | ||
| Diabetes mellitus | 6 (28.5) | 17 (30.4) |
| Cirrhosis | 5 (23.8) | 14 (25) |
| Hypertension | 4 (19.0) | 18 (32.1) |
| Ischemic heart disease | 2 (9.5) | 1 (1.8) |
| Encephalopathy | 1 (9.5) | 5 (8.9) |
| Asthma | 1 (4.8) | 0 (0) |
| Ascites | 1 (4.8) | 3 (5.4) |
| End-stage renal disease | 1 (4.8) | 7 (12.5) |
| Chronic obstructive pulmonary disease | 0 (0) | 4 (7.1) |
| Deep venous thrombosis | 0 (0) | 1 (1.8) |
| Symptoms | ||
| Fever | 11 (52.4) | 17 (30.4) |
| Cough | 6 (28.6) | 13 (23.2) |
| Dyspnea | 6 (28.6) | 20 (35.7) |
| Vomiting | 5 (23.8) | 8 (14.3) |
| Diarrhea | 3 (14.3) | 6 (10.7) |
| Headache | 3 (14.3) | 2 (3.6) |
| Pharyngitis | 0 (0) | 0 (0) |
| Rhinorrhea | 0 (0) | 0 (0) |
| Chest pain | 0 (0) | 0 (0) |
| Malaise | 0 (0) | 0 (0) |
| Transplantation Status | ||
| Liver transplant | 5 (23.8) | 4 (7.1) |
| Kidney transplant | 3 (14.3) | 4 (7.1) |
| Candidate for transplant | 8 (38.1) | 15 (26.8) |
| Time after transplant (months) | ||
| 1–3 | 0 (0) | 2 (25) |
| 3–6 | 2 (22.2) | 2 (25) |
| 6–12 | 3 (33.3) | 1 (12.5) |
| > 12 | 4 (44.4) | 3 (37.5) |